Brief: Context Therapeutics® Reports Second Quarter 2022 Operating And Financial Results
11/08/2022 21:49
Aug 11 (Reuters) - Context Therapeutics Inc CNTX.O :
* CONTEXT THERAPEUTICS® REPORTS SECOND QUARTER 2022
OPERATING AND
FINANCIAL RESULTS
* CONTEXT THERAPEUTICS - CASH, CASH EQUIVALENTS, AND
RESTRICTED
CASH WERE $42.9 MILLION AT JUNE 30, 2022
* CONTEXT THERAPEUTICS - EXPECTS THAT ITS CASH AND CASH
EQUIVALENTS WILL BE SUFFICIENT TO FUND ITS OPERATIONS INTO Q4 OF
2023
* CONTEXT THERAPEUTICS - QTRLY LOSS PER SHARE $0.25
Source text for Eikon: ID:nGNX7SnCLm
Further company coverage: CNTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202